Vimentin, which is a canonical mesenchymal marker involved in DDP-induced tumor chemotherapy resistance 47, 48, was verified as an interacting protein of CCND3 by Co-IP and immunofluorescence assays. The gene discussed is VIM; the disease is neoplasm.